一种独特的表观遗传重编程机制使PAX2沉默,并启动子宫内膜癌发生
Subhransu S Sahoo1, Susmita G Ramanand1, Ileana C Cuevas2
1Department of Pathology.
The Journal of clinical investigation
|August 19, 2025
概括
一种新的表观遗传机制在大多数子宫内膜癌中使PAX2瘤抑制剂失活. 这种与DNA突变或甲基化不同的基因组蛋白修饰提供了新的诊断和治疗点.
科学领域:
- 在瘤学瘤学.
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
- 基因组学就是基因组学.
背景情况:
- 瘤抑制基因的失活对于癌症的发展至关重要.
- 常见的机制包括DNA突变和促进剂高甲基化.
- 现在已经确定了第三种独特的表观遗传机制,涉及基因质突变.
研究的目的:
- 在子宫内膜癌中识别和描述一种新的瘤抑制器失活的机制.
- 研究PAX2基因在子宫内膜癌发生中的作用.
- 探索这种表观遗传变化的治疗含义.
主要方法:
- 对转录基因组,表观基因组和3D基因组数据的综合分析.
- 机器学习方法用于分析大型数据集.
- 使用了老鼠和人类临床前模型.
主要成果:
- 一种子宫内膜瘤抑制剂PAX2在超过80%的子宫内膜癌中被表观遗传失活.
- 这涉及到用3D基因组组织驱动的压制性H3K27me3标记取代活性色素标记.
- 失去PAX2通过全球增强器重编程促进子宫内膜癌.
结论:
- 一个新的表观遗传机制,与DNA突变或甲基化不同,在子宫内膜癌中沉默PAX2.
- 这种PAX2无活化是由抑制性组织蛋白修饰和增强剂重编程驱动的.
- 这一发现对子宫内膜癌的诊断和治疗有重大影响.
更多相关视频
07:44Non-Invasive Ultrasound Assessment of Endometrial Cancer Progression in Pax8-Directed Deletion of the Tumor Suppressors Arid1a and Pten in Mice
Published on: February 17, 2023
1.7K
10:44In Vitro Selection of Engineered Transcriptional Repressors for Targeted Epigenetic Silencing
Published on: May 5, 2023
1.5K
相关概念视频
Epigenetic Regulation
31.4K
Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
31.4K
Genomic Imprinting and Inheritance
35.2K
Diploid organisms inherit genetic material through chromosomes from both parents. Copies of the same gene are known as alleles. In most cases, both alleles are simultaneously expressed and allow various cellular processes to function optimally. If one of the alleles is missing or mutated, the expression of the other allele can compensate; however, this is not true for all genes.
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
35.2K
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Methods of Nuclear Reprogramming
1.9K
Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...
1.9K
Somatic to iPS Cell Reprogramming
2.3K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.3K
Inheritance of Chromatin Structures
6.6K
Epigenetics is the study of inherited changes in a cell's phenotype without changing the DNA sequences. It provides a form of memory for the differential gene expression pattern to maintain cell lineage, position-effect variegation, dosage compensation, and maintenance of chromatin structures such as telomeres and centromeres. For example, the structure and location of the centromere on chromosomes are epigenetically inherited. Its functionality is not dictated or ensured by the underlying...
6.6K
